2004
DOI: 10.1016/j.antiviral.2004.02.007
|View full text |Cite
|
Sign up to set email alerts
|

Isolation and characterization of herpes simplex virus type 1 resistant to aminothiazolylphenyl-based inhibitors of the viral helicase-primase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
35
0

Year Published

2005
2005
2014
2014

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 41 publications
(37 citation statements)
references
References 26 publications
2
35
0
Order By: Relevance
“…Alternatively, UL5 and UL52 may share a DNA-binding interface. The appearance of drug resistant mutations for HSV helicase-primase inhibitors in both UL5 and UL52 subunits suggests that inhibitors may bind at the interface between the UL5 and UL52 subunits (4,26,32).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Alternatively, UL5 and UL52 may share a DNA-binding interface. The appearance of drug resistant mutations for HSV helicase-primase inhibitors in both UL5 and UL52 subunits suggests that inhibitors may bind at the interface between the UL5 and UL52 subunits (4,26,32).…”
Section: Discussionmentioning
confidence: 99%
“…The sequences of the three 60-mer partially cDNA oligonucleotides, 4x12-1, 4x12-3, and 4x12-4 were described previously (17). Oligonucleotide 4x12-4 was 5Ј end labeled using [␥- 32 P]ATP (6,000 Ci/mmol [222 TBq]) and polynucleotide kinase (New England Biolabs, Beverly, MA). The labeled oligonucleotide 4x12-4 was annealed to the appropriate oligonucleotide(s) at a ratio of 1:3 in 50 mM Tris-HCl, pH 8, 50 mM NaCl, 1 mM dithiothreitol, and 0.5 mM EDTA.…”
Section: Methodsmentioning
confidence: 99%
“…Three mutant viruses were found to have mutations in their UL5 gene [171]. One had Gly352 changed to Val, one had Gly352 changed to Cys, and the third had Lys356 changed to Asn, indicating that the UL5 subunit of the HSV helicaseprimase is likely the target of the BILS inhibitors.…”
Section: Potential Antiviral Agents Sf1 Helicase Inhibitorsmentioning
confidence: 99%
“…DNAstimulated ATP hydrolysis catalyzed by purified UL5/UL52/UL8 complexes with these mutations is less sensitive to the inhibitors. Both Gly352 and Lys356 are completely conserved in all human herpesviruses [172], but the mutant viruses are viable and still cause disease [171]. The frequency with which BILS resistant mutants arise is significantly less than that seen for acyclovir-resistant mutants [171].…”
Section: Potential Antiviral Agents Sf1 Helicase Inhibitorsmentioning
confidence: 99%
“…On the other hand, mutations in the UL52 zinc finger motif affect DNA binding of the entire complex, and mutations in UL5 affect primase activity (4,16). Furthermore, mutations causing resistance to helicase-primase inhibitors have been mapped to both UL5 and UL52 subunits, suggesting that interactions of these two subunits create a composite substrate binding surface (2,5,30,36). Recent studies with subcomplexes containing various subsets of the helicase-primase complex subunits suggest that UL52-UL8 complex can polymerize nucleoside triphosphates (NTPs) onto an RNA primer-template, indicating that UL52 contains the active site for phosphodiester bond formation (14).…”
mentioning
confidence: 99%